The year in heart failure: 2004.
Massie
Barry M
BM
Cardiology Division, San Francisco VAMC, San Francisco, CA 94121, USA.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D002908:Chronic Disease; D017147:Defibrillators, Implantable; D019468:Disease Management; D006333:Heart Failure / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D008991:Monitoring, Physiologic; D011379:Prognosis; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use; D020257:Ventricular Remodeling
D000319:Adrenergic beta-Antagonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D014665:Vasodilator Agents; D006830:Hydralazine; D007548:Isosorbide Dinitrate